<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff8; src: url("8.ttf"); }
.f1 { font-family:ff8,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff12; src: url("12.ttf"); }
.f2 { font-family:ff12,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff13; src: url("13.ttf"); }
.f3 { font-family:ff13,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.ttf"); }
.f4 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff6; src: url("6.ttf"); }
.f5 { font-family:ff6,sans-serif; font-weight:normal; font-style:italic; }
@font-face { font-family: ff2; src: url("2.ttf"); }
.f6 { font-family:ff2,sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.ttf"); }
.f7 { font-family:ff0,sans-serif; font-weight:bold; font-style:normal; }
@font-face { font-family: ff3; src: url("3.ttf"); }
.f8 { font-family:ff3,sans-serif; font-weight:normal; font-style:italic; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="453" height="680" src="page11.png"">
<div class="txt" style="position:absolute; left:299px; top:44px;"><span class="f3" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Erdal B, Yalınay M, Elmas Ç, Yazıcı GN.</span></div>
<div class="txt" style="position:absolute; left:42px; top:71px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">leşemediği şeklinde yorumlanabilir. Bu izolatlardaki mutasyon varlığının ileri moleküler</span></div>
<div class="txt" style="position:absolute; left:42px; top:84px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">incelemelerle aydınlatılmasının yararlı olacağı sonucuna varılmıştır.</span></div>
<div class="txt" style="position:absolute; left:53px; top:102px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Sonuç olarak; CIP ve TZP gibi </span><span class="f5" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">P.aeruginosa</span><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">’ya yönelik antimikrobiyallerin doz aralıkla-</span></div>
<div class="txt" style="position:absolute; left:42px; top:115px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">rının tekrar değerlendirilmesinin klinik uygulamalarda önemli olacağı düşünülmektedir.</span></div>
<div class="txt" style="position:absolute; left:42px; top:128px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Klinik izolat sayısının az olması ve izolatların özel bir hasta grubuna ait olmaması çalış-</span></div>
<div class="txt" style="position:absolute; left:42px; top:141px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">manın kısıtlayıcı yanlarıdır. Bu nedenle, antimikrobiyallerin sub-MİK’lerinin </span><span class="f5" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">P.aeruginosa</span></div>
<div class="txt" style="position:absolute; left:42px; top:154px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">enfeksiyonlarının tedavi sürecine olan katkıları hakkında yeterli bilgi sağlayabilmek ama-</span></div>
<div class="txt" style="position:absolute; left:42px; top:167px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">cıyla sonuçlarımızın, daha fazla sayıda izolatın dahil edildiği geniş ölçekli çalışmalarla des-</span></div>
<div class="txt" style="position:absolute; left:42px; top:180px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">teklenmesi gerekmektedir. Ayrıca biyofilmde önemli rol aldığı düşünülen QS sisteminin</span></div>
<div class="txt" style="position:absolute; left:42px; top:193px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">moleküler yöntemlerle araştırılmasının etkin tedavi yaklaşımının planlanması açısından</span></div>
<div class="txt" style="position:absolute; left:42px; top:206px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">son derece önemli olacağı kanısına varılmıştır. </span><span class="f5" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">P.aeruginosa </span><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">virülans faktörlerinin hangi</span></div>
<div class="txt" style="position:absolute; left:42px; top:219px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">mekanizmalarla düzenlendiği ile ilgili bilgilerimizin artması, tedavide yeni gen hedefleri-</span></div>
<div class="txt" style="position:absolute; left:42px; top:232px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">nin belirlenmesini, tedavi stratejilerini ve başarısını olumlu yönde etkileyecektir.</span></div>
<div class="txt" style="position:absolute; left:42px; top:251px;"><span class="f7" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">ETİK KURUL ONAYI</span></div>
<div class="txt" style="position:absolute; left:53px; top:270px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Bu çalışma için etik kurul onayına gerek bulunmamaktadır.</span></div>
<div class="txt" style="position:absolute; left:42px; top:288px;"><span class="f7" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">ÇIKAR ÇATIŞMASI</span></div>
<div class="txt" style="position:absolute; left:53px; top:307px;"><span class="f4" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">Yazarlar bu makale ile ilgili herhangi bir çıkar çatışması bildirmemişlerdir.</span></div>
<div class="txt" style="position:absolute; left:56px; top:334px;"><span class="f7" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">KAYNAKLAR</span></div>
<div class="txt" style="position:absolute; left:42px; top:351px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">1. Lee K, Yoon SS. </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">biofilm, a programmed bacterial life for fitness. J Microbiol</span></div>
<div class="txt" style="position:absolute; left:56px; top:361px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Biotechnol 2017; 27(6): 1053-64.</span></div>
<div class="txt" style="position:absolute; left:42px; top:374px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">2. Rehman A, Patrick WM, Lamont IL. Mechanisms of ciprofloxacin resistance in </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa</span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">: new</span></div>
<div class="txt" style="position:absolute; left:56px; top:384px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">approaches to an old problem. J Med Microbiol 2019; 68(1): 1-10.</span></div>
<div class="txt" style="position:absolute; left:42px; top:397px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">3. Aykan ŞB, Çiftci İH. Meta-Analiz: Türkiye’de </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">izolatlarının son 11 yıldaki antibiyotik</span></div>
<div class="txt" style="position:absolute; left:56px; top:407px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">direnç değişimi. Mikrobiyol Bul 2015; 49(3): 352-65.</span></div>
<div class="txt" style="position:absolute; left:42px; top:420px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">4. Goel N, Bhambhwani V, Ghosh B. Multidrug-resistant </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">endophthalmitis in a silicone</span></div>
<div class="txt" style="position:absolute; left:56px; top:430px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">oil-filled eye treated with piperacillin/tazobactam: report of a case and review of literature. Int Ophtalmol</span></div>
<div class="txt" style="position:absolute; left:56px; top:440px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">2015; 35(4): 599-602.</span></div>
<div class="txt" style="position:absolute; left:42px; top:453px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">5. Pérez-Pérez M, Jorge P, Rodríguez PG, Pereira MO, Lourenço L . Quorum sensing inhibition in </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas</span></div>
<div class="txt" style="position:absolute; left:56px; top:463px;"><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">aeruginosa </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">biofilms: new insights through network mining. Biofouling 2017; 33(2): 128-42.</span></div>
<div class="txt" style="position:absolute; left:42px; top:475px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">6. Nicholas MM, Brahmchetna B, Ruxana TS. </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa </span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">biofilms: host response and clinical</span></div>
<div class="txt" style="position:absolute; left:56px; top:485px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">implications in lung infections. Am J Respir Cell Mol Biol 2018; 58(4): 428-39.</span></div>
<div class="txt" style="position:absolute; left:42px; top:498px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">7. Clinical and Laboratory Standards Institute (CLSI). M100, Performance standards for antimicrobial</span></div>
<div class="txt" style="position:absolute; left:56px; top:508px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">susceptibility testing. 2017. 27th ed. Wayne, PA</span></div>
<div class="txt" style="position:absolute; left:42px; top:521px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">8. Qu L, She P, Wang Y, Liu F, Zhang D, Chen L, et al. Effects of norspermidine on </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa</span></div>
<div class="txt" style="position:absolute; left:56px; top:531px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">biofilm formation and eradication. MicrobiologyOpen 2016; 5(3): 402-12.</span></div>
<div class="txt" style="position:absolute; left:42px; top:544px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">9. Schaber JA, Carty NL, McDonald NA, Graham ED, Cheluvappa R, Griswold JA, et al. Analysis of quorum</span></div>
<div class="txt" style="position:absolute; left:56px; top:554px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">sensing-deficient clinical isolates of </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa</span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">. J Med Microbiol 2004; 53(Pt 9): 841-53.</span></div>
<div class="txt" style="position:absolute; left:42px; top:567px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">10. Senturk S, Ulusoy S, Bosgelmez-Tinaz G, Yagcı A. Quorum sensing and virulence of </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa</span></div>
<div class="txt" style="position:absolute; left:56px; top:577px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">during urinary tract infections. J Infect Dev Ctries 2012; 6(06): 501-7.</span></div>
<div class="txt" style="position:absolute; left:42px; top:590px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">11. Pang Z, Raudonis R, Glick BR, Lin TJ, Cheng Z. Antibiotic resistance in </span><span class="f8" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">Pseudomonas aeruginosa</span><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">: mechanisms</span></div>
<div class="txt" style="position:absolute; left:56px; top:600px;"><span class="f4" style="font-size:7px;vertical-align:baseline;color:rgba(35,31,31,1);">and alternative therapeutic strategies. Biotechnol Adv 2019; 37(1): 177-92.</span></div>
<div class="txt" style="position:absolute; left:43px; top:628px;"><span class="f2" style="font-size:8px;vertical-align:baseline;color:rgba(35,31,31,1);">MİKROBİYOLOJİ BÜLTENİ</span></div>
<div class="txt" style="position:absolute; left:392px; top:628px;"><span class="f1" style="font-size:9px;vertical-align:baseline;color:rgba(35,31,31,1);">557</span></div>
</body>
</html>
